Arif Bilal
SEC CIK 1959750 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | Chief Tech Ops Off | 32.5K | — | $2.18M | 20 | 2023-03-01 | 2025-03-10 |
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
Arif Bilal made no open-market trades at SRPT in the last 12 months.
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | A - Grant | — | +8,276 | 32.5K | +34% | — |
| D | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $100.13 | -523 | 24.2K | -2% | -$52.4K |
| D | 2025-03-10 | 2025-03-06 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | M - OptEx | — | +17.5K | 33.8K | +107% | — |
| DM | 2025-03-10 | 2025-03-07 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $103.70 | -9,035 | 24.7K | -27% | -$936.9K |
| M | 2025-03-06 | 2025-03-04 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $101.34 | -514 | 16.3K | -3% | -$52.1K |
| 2025-03-04 | 2025-03-03 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $103.77 | -719 | 16.8K | -4% | -$74.6K | |
| DMT | 2024-06-25 | 2024-06-24+ | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | S - Sale+OE | $163.13 | -11.8K | 22.2K | -35% | -$1.92M |
| DT | 2024-06-25 | 2024-06-24 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $164.64 | -2,352 | 29.1K | -7% | -$387.2K |
| DT | 2024-06-25 | 2024-06-21 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | M - OptEx | — | +6,250 | 31.5K | +25% | — |
| M | 2024-03-11 | 2024-03-07+ | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $121.77 | -978 | 25.7K | -4% | -$119.1K |
| M | 2024-03-06 | 2024-03-04 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $125.32 | -522 | 26.2K | -2% | -$65.4K |
| DM | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $126.19 | -365 | 22.8K | -2% | -$46.1K |
| DM | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | S - Sale | $128.84 | -2,000 | 27.3K | -7% | -$257.7K |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | A - Grant | $0.00 | +6,000 | 28.8K | +26% | $0 |
| 2023-12-05 | 2023-12-01 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $80.34 | -3,682 | 22.9K | -14% | -$295.8K | |
| 2023-04-04 | 2023-03-30 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $136.66 | -307 | 26.4K | -1% | -$42.0K | |
| 2023-03-10 | 2023-03-08 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $153.19 | -314 | 26.7K | -1% | -$48.1K | |
| DM | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $157.21 | -340 | 22.5K | -1% | -$53.5K |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | A - Grant | $0.00 | +4,500 | 27.0K | +20% | $0 |
| M | 2023-03-03 | 2023-03-01 | SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Off | F - Tax | $147.57 | -252 | 22.8K | -1% | -$37.2K |
Purchase Sale Sale after option exercise All abbreviations